Actively Recruiting
Clinical Trial of Concomitant Hip Arthroscopy During PAO
Led by Mayo Clinic · Updated on 2025-09-05
106
Participants Needed
1
Research Sites
562 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.
CONDITIONS
Official Title
Clinical Trial of Concomitant Hip Arthroscopy During PAO
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of hip dysplasia electing periacetabular osteotomy (PAO) for treatment
- Skeletally mature
- Age 15 to 55 years
- Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis)
- Ability to receive a standard preoperative MRI arthrogram of the hip
You will not qualify if you...
- Pregnant women
- Previous surgery on the hip
- Patients receiving PAO for acetabular retroversion without hip dysplasia
- Previous hip arthroscopy to treat intraarticular hip problems
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Cody Wyles, MD
CONTACT
L
Lauren Cole
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here